Stability of cephalexin monohydrate suspension in polypropylene oral syringes.
The stability of cephalexin monohydrate suspension in plastic oral syringes was studied. Commercially available cephalexin monohydrate powder for oral administration was reconstituted according to the manufacturer's instructions and stored in the original containers or drawn into 5-mL clear polypropylene oral syringes. The original containers and syringes were divided into groups and stored at -20, 4, 25, 40, 60, or 80 degrees C. Powder from two additional lots was similarly reconstituted and packaged; these original containers and syringes were stored at 80 degrees C only to assess interlot variability. Immediately after reconstitution and at specified times during storage, three syringes and the corresponding three original containers stored at each temperature were removed, and their contents were analyzed for cephalexin concentration using the standard USP iodometric assay for antibiotics. The stability-indicating nature of the assay was documented. Cephalexin monohydrate followed a first-order rate of degradation at temperatures of 40, 60, and 80 degrees C. At temperatures of -20, 4, and 25 degrees C, cephalexin monohydrate exhibited no appreciable degradation during the 90-day study period. Cephalexin monohydrate suspension reconstituted from powder as a suspension and repackaged in clear polypropylene oral syringes was stable for 90 days when stored under ambient, refrigerated, and frozen conditions.
Sylvestri
M F
MF
School of Pharmacy and Allied Health Professions, Creighton University, Omaha, NE.
Makoid
M C
MC
Cox
B E
BE
D000284:Administration, Oral; D002506:Cephalexin / Q000008:administration & dosage / Q000032:analysis*; D004355:Drug Stability; D011126:Polypropylenes; D013535:Suspensions; D013594:Syringes
D011126:Polypropylenes; D013535:Suspensions; D002506:Cephalexin